DIAGNOSTIC PRODUCTS CORP
10-Q, EX-27, 2000-11-13
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: DIAGNOSTIC PRODUCTS CORP, 10-Q, 2000-11-13
Next: FIRST MIDWEST BANCORP INC, 10-Q, 2000-11-13



<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                          12,354
<SECURITIES>                                         0
<RECEIVABLES>                                   68,442
<ALLOWANCES>                                       761
<INVENTORY>                                     60,166
<CURRENT-ASSETS>                               144,294
<PP&E>                                         109,333
<DEPRECIATION>                                  58,534
<TOTAL-ASSETS>                                 261,748
<CURRENT-LIABILITIES>                           43,686
<BONDS>                                              0
                                0
                                          0
<COMMON>                                        42,075
<OTHER-SE>                                     175,987
<TOTAL-LIABILITY-AND-EQUITY>                   261,748
<SALES>                                        183,408
<TOTAL-REVENUES>                               183,408
<CGS>                                           81,849
<TOTAL-COSTS>                                   81,849
<OTHER-EXPENSES>                                53,128
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                 28,721
<INCOME-TAX>                                     9,004
<INCOME-CONTINUING>                             19,717
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    19,717
<EPS-BASIC>                                       1.44
<EPS-DILUTED>                                     1.41


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission